But Wall Street sees a rally in Ulta's future, with the average price target suggesting 23% upside for the stock over the next year, according to FactSet.
Slightly less than half of analysts rate the stock a buy.
Health-care stock HCA is favored more, with about two-thirds of analysts recommending it as a buy.
Nearly seven out of every 10 analysts rate the stock a buy, with an average price target implying shares could rise nearly 9%, according to FactSet.
The consensus price target among analysts has IBM gaining less than 1% over the next year, while Packaging Corp. could tumble nearly 8%.
Persons:
Ulta
Organizations:
Health, HCA, Marathon Petroleum, Marathon, IBM, Packaging Corporation of America, Packaging Corp, Packaging Corporation
Locations:
Ulta's